Answering Your Frequently Asked Questions
We've collated some frequently asked questions for you. If you have any other questions which are not answered below, or would like more information please email the team - info@hansonwade.com.
The 15th Tumour Models Summit London is Europe's leading forum dedicated to preclinical and translational tumour modelling. Bringing together 140+ experts from pharma, biotech and solution providers, the summit will explore how to optimise model selection by balancing reproducibility, cost and speed to accelerate clinical translation. Attendees will gain practical insights into combining in vivo, in vitro and computational approaches to improve decision-making and advance oncology drug development.
The 15th Tumour Models Summit London will take place on 2-3 December 2026 in London, UK. The meeting consists of two dedicated conference days featuring presentations, panel discussions, networking opportunities and industry case studies.
This summit is designed for professionals involved in oncology drug discovery, preclinical development and translational research, including:
- Biology and Bioscience Leaders
- Discovery and Early Discovery Scientists
- Preclinical and Non-Clinical Researchers
- Translational Scientists
- In Vivo and In Vitro Specialists
- Pharmacology Teams
- Computational and In Silico Researchers
- Oncology R&D Leaders
Whether you are working to improve translatability, evaluate new models or accelerate development timelines, the summit offers valuable insights at every stage of preclinical oncology research.
The agenda will focus on the critical challenges shaping tumour modelling today, including:
- Selecting the right model while balancing cost, speed and biological relevance
- Improving confidence in human-relevant models and New Approach Methodologies (NAMs)
- Understanding which models best predict clinical success
- Modelling the tumour microenvironment more accurately
- Using AI and computational modelling to improve development decisions
- Enhancing reproducibility across tumour models
- Predicting safety and therapeutic index earlier in development
- Identifying and validating novel oncology targets
- Understanding evolving regulatory expectations surrounding animal testing and alternative models
Attendees will hear real-world case studies spanning organoids, spheroids, PDX models, humanised mouse models, organ-on-chip platforms, 3D bioprinting and AI-driven approaches.
You can register directly through the official event website. Simply visit the registration page and submit your details to secure your place.
If you have any questions about eligibility, group bookings or registration options, our team will be happy to assist.
The full event guide is available to download from the website and provides detailed information on the agenda, speakers, attending organisations, key discussion topics and partnership opportunities. See more info here.
If you cannot find the download link, please contact the event team and we will send you a copy directly.
If you have questions about registration, speaking opportunities, sponsorship packages or the event programme, please contact the Tumour Models Summit team here.
Our team will be happy to help with any enquiries and provide additional information about attending, partnering or presenting at the summit.